How many institutions held CYCN - Cyclerion Therapeutics, Inc. - Common Stock, no par value in Q3 2024?

15 institutional investors reported CYCN - Cyclerion Therapeutics, Inc. - Common Stock, no par value for Q3 2024. Use the holders table for investor-level position and value details.

Cyclerion Therapeutics, Inc. - Common Stock, no par value (CYCN)

Q: What does CUSIP 23255M204 represent in this 13F holders report?

CUSIP 23255M204 is the security identifier for CYCN - Cyclerion Therapeutics, Inc. - Common Stock, no par value used to aggregate holder disclosures.

CUSIP: 23255M204

Q3 2024 13F Holders as of 30 Sep 2024

Security type / class: Equity / Common Stock, no par value
Shares outstanding: 3,367,000
Total 13F shares: 1,042,639
Share change: -124,854
Total reported value: $2,696,608
Reported price per share: $2.59
Number of holders: 15
Value change: -$289,148
Number of buys: 1
Number of sells: 7

Security key

23255M204

Report period

Q3 2024

Institutions

Top holders

CYCN full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2024 Previous quarter: Q2 2024 Cyclerion Therapeutics, Inc. SEC filings Cyclerion Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 23255M204

Newer quarter: Q4 2024 Previous quarter: Q2 2024

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top shareholders of CYCN - Cyclerion Therapeutics, Inc. - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

Slate Path Capital LP

13D/G signal

—

Evidence rows

Latest as of

05 Aug 2024

13F 3/4/5 Lead comparable stake: 11% Showing first 8 of 31 holder rows. Open remaining rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Slate Path Capital LP	13F Company 13F	11%	$823,124 357,880 shares	—	30 Jun 2024
MFN Partners Management, LP	13F Company 13F	5%	$386,369 169,460 shares	—	30 Jun 2024
TYNDALL CAPITAL PARTNERS L P	13F Company 13F	4.9%	$378,987 164,777 shares	—	30 Jun 2024
FMR LLC	13F Company 13F	4.8%	$368,035 161,419 shares	—	30 Jun 2024
Artal Group S.A.	13F Company 13F	3.5%	$270,579 117,643 shares	—	30 Jun 2024
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	1%	$77,492 33,978 shares	—	30 Jun 2024
VANGUARD GROUP INC	13F Company 13F	0.7%	$54,027 23,490 shares	—	30 Jun 2024
BlackRock Finance, Inc.	13F Company 13F	0.51%	$39,489 17,169 shares	—	30 Jun 2024

Show 23 additional holder rows in the full holder list

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
UBS Group AG	13F Company 13F	0.08%	$6,224 2,706 shares	—	30 Jun 2024
Tower Research Capital LLC (TRC)	13F Company 13F	0.04%	$3,367 1,464 shares	—	30 Jun 2024
MORGAN STANLEY	13F Company 13F	0.02%	$1,493 649 shares	—	30 Jun 2024
GROUP ONE TRADING LLC	13F Company 13F	0.02%	$1,231 540 shares	—	30 Jun 2024
ROYAL BANK OF CANADA	13F Company 13F	0.01%	$1,000 416 shares	—	30 Jun 2024
Activest Wealth Management	13F Company 13F	0%	$230 100 shares	—	30 Jun 2024
BANK OF AMERICA CORP /DE/	13F Company 13F	0%	$37 16 shares	—	30 Jun 2024
PNC FINANCIAL SERVICES GROUP, INC.	13F Company 13F	0%	$5 2 shares	—	30 Jun 2024
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F Company 13F	0%	$2 1 shares	—	30 Jun 2024
Regina M. Graul	3/4/5 President and Chief Executive Officer, Director 3/4/5	— mixed-class rows	$340,529 156,152 shares mixed-class rows	—	05 Aug 2024
Terrance McGuire	3/4/5 Director 3/4/5	— class O/S missing	$142,624 42,010 shares	—	30 Nov 2023
Errol B. Desouza	3/4/5 Director 3/4/5	— class O/S missing	$101,850 30,000 shares	—	30 Nov 2023
Dina Katabi	3/4/5 Director 3/4/5	— class O/S missing	$67,900 20,000 shares	—	30 Nov 2023
Steven Hyman	3/4/5 Director 3/4/5	— class O/S missing	$67,900 20,000 shares	—	30 Nov 2023
Andreas Busch	3/4/5 Chief Scientific Officer 3/4/5	— class O/S missing	— 135,000 shares	—	20 Jan 2022
Anjeza Gjino	3/4/5 Chief Financial Officer 3/4/5	— class O/S missing	— 135,000 shares	—	20 Jan 2022
Cheryl Gault	3/4/5 Chief Operating Officer 3/4/5	— class O/S missing	— 135,000 shares	—	20 Jan 2022
George H. Conrades	3/4/5 Director 3/4/5	— class O/S missing	— 20,000 shares	—	14 Jun 2022
Marsha Fanucci	3/4/5 Director 3/4/5	— class O/S missing	— 20,000 shares	—	14 Jun 2022
Michael Mendelsohn	3/4/5 Director 3/4/5	— class O/S missing	— 20,000 shares	—	14 Jun 2022
Ole Isacson	3/4/5 Director 3/4/5	— class O/S missing	— 20,000 shares	—	14 Jun 2022
Stephanie Lovell	3/4/5 Director 3/4/5	— class O/S missing	— 20,000 shares	—	14 Jun 2022
Kevin Churchwell	3/4/5 Director 3/4/5	— class O/S missing	— 10,000 shares	—	24 Jun 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,042,639

Rows loaded

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders

Q3 2024 holders

Holder diff

-2

Investor	Q2 2024 Shares	Q3 2024 Shares	Share Diff	Share Chg %	Q2 2024 value	Q3 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend